Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

153.44 +7.78 (+5.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,088,929
Open 145.32
Bid (Size) 134.00 (200)
Ask (Size) 165.00 (500)
Prev. Close 145.66
Today's Range 145.32 - 155.13
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Repligen (NASDAQ:RGEN) and its peers. 
Via StockStory

Performance

YTD
+7.3%
+7.3%
1 Month
+3.2%
+3.2%
3 Month
+26.4%
+26.4%
6 Month
+16.6%
+16.6%
1 Year
+10.0%
+10.0%

More News

Read More
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call
Via StockStory
Topics Earnings
Earnings Scheduled For October 28, 2025
Via Benzinga
3 Hyped Up Stocks with Open Questions
Via StockStory
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset
Via StockStory
Why Repligen (RGEN) Shares Are Trading Lower Today
Via StockStory
Topics Economy Government World Trade
Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates
Via Chartmill
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates
Via StockStory
Topics Earnings
Repligen Earnings: What To Look For From RGEN
Via StockStory
Topics Artificial Intelligence
3 Inflated Stocks with Questionable Fundamentals
Via StockStory
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy Government
What 8 Analyst Ratings Have To Say About Repligen
Via Benzinga
Why Is Repligen (RGEN) Stock Soaring Today
Via StockStory
Topics Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
1 Volatile Stock to Target This Week and 2 Facing Challenges
Via StockStory
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
Via StockStory
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Repligen (RGEN) Stock Is Up, What You Need To Know
Via StockStory
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 153.44
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 8.54B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.